Nine years follow-up after TVT-O; the mesh still available for women suffering from urinary incontinence

dc.contributor.authorWarro Aino
dc.contributor.authorOjala Johanna
dc.contributor.authorAla-Nissilä Seija
dc.contributor.authorLaurikainen Eija
dc.contributor.organizationfi=synnytys- ja naistentautioppi|en=Obstetrics and Gynaecology|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.74725736230
dc.converis.publication-id178862904
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/178862904
dc.date.accessioned2025-08-27T22:36:25Z
dc.date.available2025-08-27T22:36:25Z
dc.description.abstract<p><b>Objective:</b> The efficacy of TVT-O is well established in patients with stress urinary incontinence (SUI). The objective of this study was to evaluate the efficacy, safety and patient satisfaction of TVT-O in patients suffer-ing from primary or recurrent SUI or mixed urinary incontinence (MUI).<br></p><p><b>Methods:</b> A single-center follow-up study was conducted. All consecutive women treated by TVT-O between August 2004 and October 2011 were included. Objective treatment success was a negative stress test. Patient satisfaction was assessed by questionnaires.<br></p><p><b>Results:</b> The mean time from the surgery to the last follow-up visit was 9 years. One hundred and six patients were included in the final evaluation. Nineteen patients (18%) were previously operated on for urinary incon-tinence (UI). Ninety patients (85%) were objectively cured; 68 (89%) of the SUI and 22 (73%) of the MUI patients (p = 0.067). Fourteen (74%) of the previously operated patients and 76 (87%) of the patients who underwent first-time TVT-O were objectively cured (p = 0.158). Eighty-six patients (81%) achieved subjective success; 70 (92%) of the SUI and sixteen (53%) of the MUI patients (p<0.001). Eleven women (58%) who had repeat surgery and 75 women (86%) who had primary operation were subjectively cured (p = 0.008).<br></p><p><b>Conclusions:</b> TVT-O is effective in women who suffer from SUI having 90% objective and subjective cure rate 9 years after surgery. There were no major complications, but 16% of the women suffered from groin pain and 37% had urgency symptoms. The results of TVT-O were still good, and it is a therapeutic alternative for different subgroups of UI including recurrent cases.<br></p><p>(c) 2023 The Authors. Published by Elsevier Masson SAS. <br></p><p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)</p>
dc.identifier.jour-issn2468-8495
dc.identifier.olddbid202457
dc.identifier.oldhandle10024/185484
dc.identifier.urihttps://www.utupub.fi/handle/11111/47028
dc.identifier.urlhttps://doi.org/10.1016/j.jogoh.2023.102534
dc.identifier.urnURN:NBN:fi-fe2023031431456
dc.language.isoen
dc.okm.affiliatedauthorWarro, Aino
dc.okm.affiliatedauthorOjala, Johanna
dc.okm.affiliatedauthorAla-Nissilä, Seija
dc.okm.affiliatedauthorLaurikainen, Eija
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3123 Gynaecology and paediatricsen_GB
dc.okm.discipline3123 Naisten- ja lastentauditfi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherELSEVIER MASSON, CORP OFF
dc.publisher.countryFranceen_GB
dc.publisher.countryRanskafi_FI
dc.publisher.country-codeFR
dc.relation.articlenumber102534
dc.relation.doi10.1016/j.jogoh.2023.102534
dc.relation.ispartofjournalJournal of gynecology obstetrics and human reproduction
dc.relation.issue3
dc.relation.volume52
dc.source.identifierhttps://www.utupub.fi/handle/10024/185484
dc.titleNine years follow-up after TVT-O; the mesh still available for women suffering from urinary incontinence
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S2468784723000028-main.pdf
Size:
620.6 KB
Format:
Adobe Portable Document Format